BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

126 related articles for article (PubMed ID: 26552366)

  • 21. A novel carbohydrate-based therapeutic GCS-100 overcomes bortezomib resistance and enhances dexamethasone-induced apoptosis in multiple myeloma cells.
    Chauhan D; Li G; Podar K; Hideshima T; Neri P; He D; Mitsiades N; Richardson P; Chang Y; Schindler J; Carver B; Anderson KC
    Cancer Res; 2005 Sep; 65(18):8350-8. PubMed ID: 16166312
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Antitumor activity of lysophosphatidic acid acyltransferase-beta inhibitors, a novel class of agents, in multiple myeloma.
    Hideshima T; Chauhan D; Hayashi T; Podar K; Akiyama M; Mitsiades C; MItsiades N; Gong B; Bonham L; de Vries P; Munshi N; Richardson PG; Singer JW; Anderson KC
    Cancer Res; 2003 Dec; 63(23):8428-36. PubMed ID: 14679006
    [TBL] [Abstract][Full Text] [Related]  

  • 23. XIAP regulates Akt activity and caspase-3-dependent cleavage during cisplatin-induced apoptosis in human ovarian epithelial cancer cells.
    Asselin E; Mills GB; Tsang BK
    Cancer Res; 2001 Mar; 61(5):1862-8. PubMed ID: 11280739
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Transcription factor AP-2alpha is preferentially cleaved by caspase 6 and degraded by proteasome during tumor necrosis factor alpha-induced apoptosis in breast cancer cells.
    Nyormoi O; Wang Z; Doan D; Ruiz M; McConkey D; Bar-Eli M
    Mol Cell Biol; 2001 Aug; 21(15):4856-67. PubMed ID: 11438643
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Antitumor effects of (S)-HDAC42, a phenylbutyrate-derived histone deacetylase inhibitor, in multiple myeloma cells.
    Bai LY; Omar HA; Chiu CF; Chi ZP; Hu JL; Weng JR
    Cancer Chemother Pharmacol; 2011 Aug; 68(2):489-96. PubMed ID: 21072520
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Inhibition of caspase activity delays apoptosis in a transfected NS/0 myeloma cell line.
    McKenna SL; Cotter TG
    Biotechnol Bioeng; 2000 Jan; 67(2):165-76. PubMed ID: 10592514
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Janus activated kinase 2/signal transducer and activator of transcription 3 pathway mediates icariside II-induced apoptosis in U266 multiple myeloma cells.
    Kim SH; Ahn KS; Jeong SJ; Kwon TR; Jung JH; Yun SM; Han I; Lee SG; Kim DK; Kang M; Chen CY; Lee JW; Kim SH
    Eur J Pharmacol; 2011 Mar; 654(1):10-6. PubMed ID: 21172343
    [TBL] [Abstract][Full Text] [Related]  

  • 28. The DegraBase: a database of proteolysis in healthy and apoptotic human cells.
    Crawford ED; Seaman JE; Agard N; Hsu GW; Julien O; Mahrus S; Nguyen H; Shimbo K; Yoshihara HA; Zhuang M; Chalkley RJ; Wells JA
    Mol Cell Proteomics; 2013 Mar; 12(3):813-24. PubMed ID: 23264352
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Caspase cleavage of exon 9 deleted presenilin-1 is an early event in apoptosis induced by calcium ionophore A 23187 in SH-SY5Y neuroblastoma cells.
    Popescu BO; Cedazo-Minguez A; Popescu LM; Winblad B; Cowburn RF; Ankarcrona M
    J Neurosci Res; 2001 Oct; 66(1):122-34. PubMed ID: 11599009
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Role of the phosphatidylinositol 3-kinase/Akt and mTOR/P70S6-kinase pathways in the proliferation and apoptosis in multiple myeloma.
    Pene F; Claessens YE; Muller O; ViguiƩ F; Mayeux P; Dreyfus F; Lacombe C; Bouscary D
    Oncogene; 2002 Sep; 21(43):6587-97. PubMed ID: 12242656
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Activation of caspase-3 and c-Jun NH2-terminal kinase-1 signaling pathways in tamoxifen-induced apoptosis of human breast cancer cells.
    Mandlekar S; Yu R; Tan TH; Kong AN
    Cancer Res; 2000 Nov; 60(21):5995-6000. PubMed ID: 11085519
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Circulating proteolytic signatures of chemotherapy-induced cell death in humans discovered by N-terminal labeling.
    Wiita AP; Hsu GW; Lu CM; Esensten JH; Wells JA
    Proc Natl Acad Sci U S A; 2014 May; 111(21):7594-9. PubMed ID: 24821784
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Diallyl trisulfide-induced apoptosis of bladder cancer cells is caspase-dependent and regulated by PI3K/Akt and JNK pathways.
    Shin DY; Kim GY; Hwang HJ; Kim WJ; Choi YH
    Environ Toxicol Pharmacol; 2014 Jan; 37(1):74-83. PubMed ID: 24309133
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Synergistic induction of oxidative injury and apoptosis in human multiple myeloma cells by the proteasome inhibitor bortezomib and histone deacetylase inhibitors.
    Pei XY; Dai Y; Grant S
    Clin Cancer Res; 2004 Jun; 10(11):3839-52. PubMed ID: 15173093
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Global sequencing of proteolytic cleavage sites in apoptosis by specific labeling of protein N termini.
    Mahrus S; Trinidad JC; Barkan DT; Sali A; Burlingame AL; Wells JA
    Cell; 2008 Sep; 134(5):866-76. PubMed ID: 18722006
    [TBL] [Abstract][Full Text] [Related]  

  • 36. In-Depth Characterization of Apoptosis N-Terminome Reveals a Link Between Caspase-3 Cleavage and Posttranslational N-Terminal Acetylation.
    Hanna R; Rozenberg A; Saied L; Ben-Yosef D; Lavy T; Kleifeld O
    Mol Cell Proteomics; 2023 Jul; 22(7):100584. PubMed ID: 37236440
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Interactome disassembly during apoptosis occurs independent of caspase cleavage.
    Scott NE; Rogers LD; Prudova A; Brown NF; Fortelny N; Overall CM; Foster LJ
    Mol Syst Biol; 2017 Jan; 13(1):906. PubMed ID: 28082348
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Identification of proteolytic cleavage sites by quantitative proteomics.
    Enoksson M; Li J; Ivancic MM; Timmer JC; Wildfang E; Eroshkin A; Salvesen GS; Tao WA
    J Proteome Res; 2007 Jul; 6(7):2850-8. PubMed ID: 17547438
    [TBL] [Abstract][Full Text] [Related]  

  • 39. A novel NF-kappaB inhibitor DHMEQ selectively targets constitutive NF-kappaB activity and induces apoptosis of multiple myeloma cells in vitro and in vivo.
    Watanabe M; Dewan MZ; Okamura T; Sasaki M; Itoh K; Higashihara M; Mizoguchi H; Honda M; Sata T; Watanabe T; Yamamoto N; Umezawa K; Horie R
    Int J Cancer; 2005 Mar; 114(1):32-8. PubMed ID: 15523684
    [TBL] [Abstract][Full Text] [Related]  

  • 40. 4-Hydroxytamoxifen inhibits proliferation of multiple myeloma cells in vitro through down-regulation of c-Myc, up-regulation of p27Kip1, and modulation of Bcl-2 family members.
    Gauduchon J; Gouilleux F; Maillard S; Marsaud V; Renoir JM; Sola B
    Clin Cancer Res; 2005 Mar; 11(6):2345-54. PubMed ID: 15788686
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.